64157FAA1
Nevro Corp
Could not find a ticker for this position, may be a filing error
A medical device company that builds implantable spinal cord stimulators to treat chronic pain. Its Senza and HFX systems deliver a high-frequency "10 kHz Therapy" that eases pain without the tingling sensation older stimulators cause. Founded in 2006 by engineer Konstantinos Alataris, the company's name comes from the Greek word for "nerve." Its first product launched in 2015, and its devices are used by pain specialists around the world.
CONVERTIBLEUnderlying: NVROCUSIP: 64157FAA1HealthcareUS1 derivative reporter
1.75% Convertible Senior Notes due 2021
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
